What is EXL.AX's gross margin?

Elixinol (EXL.AX) has a gross margin of 17% and a net margin of -15%.

What is EXL.AX's P/E ratio?

Track Elixinol (EXL.AX) P/E ratio, ROE, and valuation metrics over time.

Where can I see EXL.AX's full financials?

See Elixinol (EXL.AX) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

Elixinol (EXL.AX) Financials — Revenue, Earnings, Cash Flow

Also trades as: ELLXF (OTC) · $vol 0M

A$0.01 ($0.01)

+0.00 (+14.29%)

Weekly Expected Move ±18.9%

A$0 A$0 A$0 A$0 A$0

ASX · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Strong Sell · Power 36 · A$2.9M mcap · 388M float · 0.203% daily turnover

Overview Chart Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers

📊 Key Metrics

TTM

A$31M

Revenue

+356.3% YoY

A$-6M

Net Income

-100.9% YoY

A$-5M

Free Cash Flow

-144.3% YoY

16.8%

Gross Margin

-8.4%

Op. Margin

-14.9%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-80.3%

ROA-40.4%

ROIC-55.1%

Valuation

P/E-0.7

P/B0.5

EV/EBITDA-0.8

Leverage

Debt/Equity0.63

Current Ratio0.78

Interest Cov.-9.7x

Quality Scores

Piotroski F3/9

Altman Z-21.36

Beneish M-1.31